NEU 6.41% $15.27 neuren pharmaceuticals limited

Clearly, all three are going the same way IMO. So let's price...

  1. 2,035 Posts.
    lightbulb Created with Sketch. 479
    Clearly, all three are going the same way IMO. So let's price the bad news in and get on with it.

    Just so disappointing!

    If I was a believer in conspiracy theories...the timing, the hold period preventing further P2 progress, the proximity to the P3 result...well it's a good thing I don't believe in conspiracy theories.

    I wonder about 'degree' in this FDA feedback. They are now asking for a change, but is it a change to an agreed standard already submitted, is it an additional standard or protocol, is it something NEU missed (I doubt that with this team's experience).

    Many questions.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.